跳至主要内容
临床试验/ACTRN12618001745235
ACTRN12618001745235已完成2 期

Caffeine prophylaxis to improve intermittent hypoxaemia in infants born late preterm: a randomised controlled dosage trial (Latte Dosage Trial)

The University of Auckland0 个研究点目标入组 132 人开始时间: 2018年10月24日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
132

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
Hours 至 50 Years(—)
性别
All

入选标准

  • Infants born between 34+0 – 36+6 weeks’ GA without contradiction to caffeine treatment and are 72 hours of age or less.
  • Mother's who have given birth to an infant who is of 34+0 - 36+6 GA

排除标准

  • Major congenital abnormality
  • Minor congenital abnormality likely to affect respiration, growth or development
  • Previous caffeine treatment
  • Renal or hepatic impairment
  • Tachyarrhythmia
  • Hypoxic ischaemic encephalopathy
  • Residing outside of the Auckland DHB regions
  • Mother's who have given birth to an infant who has any of the exclusion criteria listed above

研究者

相似试验